Abstract
(1013 Views) |
Full-Text (PDF)
(427 Downloads)
|
Full-Text (HTML)
(333 Views)
|
Highlights
● Patients with Multiple Sclerosis (MS) and epilepsy experienced depression, anxiety, stress, fear, poor sleep quality, mental fatigue, and poor quality of life during the Coronavirus Disease 2019 (COVID-19) pandemic.
● Quarantine has limited patients’ access to medication and treatment, resulting in increased seizure attacks and disease severity.
● Factors such as female gender, loneliness, economic problems, the lack of social support, old age, and the lack of exercise also affected the severity of depressive symptoms, stress, and anxiety in patients with MS and epilepsy during the COVID-19 pandemic.